| 461 |
DERMIVEX DUSTING POWDER |
CLOTRIMAZOLE USP 1 % W/W |
POWDER |
TUBE |
FOR PREVENTION OR TREATMENT OR FUNGAL INFECTIONS SUCH AS RINGWORMS, DHOBIE ITCH (FUNGAL INFECTION ON THE SKIN OF THE GROIN REGION), ATHLETE'S FOOT AND INFECTION RESULTING FROM EXCESSIVE SWEATING) |
No |
VE PRODUCTS (LAO) CO.,LTD |
OM SAI PHARMA PACK |
INDIA |
CERTIFICATE RELEASED |
12 I 5829/24 |
2024-12-16 |
2029-12-15 |
View |
| 462 |
QUATREX EAR DROPS |
CLOTRIMAZOLE USP 1 % W/V, CHLORAMPHENICOL BP 5% W/V, ANHUDROUS BECLOMETHASONE DIPROPIONATE BP 0.025 % W/V, LIDOCAINE HYDROCHLORIDE BP 2% W/V |
EAR DROPS |
BOTTLE |
TO TREAT EAR INFECTIONS BY RELIEVING INFLAMMATION AND TARGETING THE BACTERIA AND FUNGI RESPONSIBLE FOR SYMPTOMS, IT CAN ALSO RELIEVE PAIN BY FUNCTIONING AS A LOCAL ANESTHETIC |
No |
VE PRODUCTS (LAO) CO.,LTD |
OM SAI PHARMA PACK |
INDIA |
CERTIFICATE RELEASED |
12 I 5830/24 |
2024-12-16 |
2029-12-15 |
View |
| 463 |
ESCIVEX 10 |
Escitalopram 10 mg |
Film coated Tablets |
Alu-Alu Blister |
Treatment of major depressive episodes, Treatment of panic disorder with or without agoraphobia.
,Treatment of social anxiety disorder (social phobia), Treatment of generalised anxiety disorder, Treatment of obsessive-compulsive disorder |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5834/24 |
2024-12-30 |
2029-12-29 |
View |
| 464 |
MONVEX-L |
Levocetirizine Dihydrochloride USP 5 mg, Montelukast Sodium Eq. to. Montelukast
BP 10 mg |
Film coated Tablets |
Alu-Alu Blister |
for the relief of symptoms associated with seasonal and perennial allergic rhinitis. |
No |
VE PRODUCTS (LAO) CO.,LTD |
4Care Lifescience Pvt. Ltd. |
INDIA |
CERTIFICATE RELEASED |
12 I 5835/24 |
2024-12-30 |
2029-12-29 |
View |
| 465 |
OLAVEX 10 |
Olanzapine USP 10 mg |
Tablets |
Alu-Alu Blister |
for the treatment of schizophrenia, for the treatment of moderate to severe manic episode, In patients whose manic episode has responded to OLAVEX treatment, OLAVEX is indicated for the prevention of recurrence in patients with bipolar disorder |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5836/24 |
2024-12-30 |
2029-12-29 |
View |
| 466 |
OLAVEX 5 MD |
Olanzapine USP 5 mg |
Tablets |
Alu-Alu Blister |
for the treatment of schizophrenia, for the treatment of moderate to severe
manic episode, In patients whose manic episode has responded to OLAVEX
treatment, OLAVEX is indicated for the prevention of recurrence
in patients with bipolar disorder |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5837/24 |
2024-12-30 |
2029-12-29 |
View |
| 467 |
VEXGID 80 |
Gliclazide BP 80 mg |
Tablets |
Alu-Alu Blister |
Non-insulin dependent diabetes (type 2) |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5838/24 |
2024-12-30 |
2029-12-29 |
View |
| 468 |
Vexgid MR 30 |
Gliclazide BP 30 mg |
Tablets |
Alu-Alu Blister |
Non-insulin dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss along are not sufficient to control blood glucose. |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5839/24 |
2024-12-30 |
2029-12-29 |
View |
| 469 |
Vexgid MR 60 |
Gliclazide BP 60 mg |
Tablets |
Alu-Alu Blister |
Non-insulin dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss along are not sufficient to control blood glucose. |
No |
VE PRODUCTS (LAO) CO.,LTD |
WEST-COAST PHARMACEUTICAL WORKS LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5840/24 |
2024-12-30 |
2029-12-29 |
View |
| 470 |
VEXLEV 250 |
LEVETIRACETAM USP 250 mg |
Film coated Tablets |
Alu-Alu Blister |
Monotherapy of focal seizures with or without secondary generalisation
Adjunctive therapy of focal seizures with or without secondary generalisation
Adjunctive therapy of myoclonic seizures and tonic-clonic seizures |
No |
VE PRODUCTS (LAO) CO.,LTD |
4Care Lifescience Pvt. Ltd. |
INDIA |
CERTIFICATE RELEASED |
12 I 5841/24 |
2024-12-30 |
2029-12-29 |
View |
